Literature DB >> 29380369

Development, current applications and future roles of biorelevant two-stage in vitro testing in drug development.

Tom Fiolka1, Jennifer Dressman1.   

Abstract

OBJECTIVES: Various types of two stage in vitro testing have been used in a number of experimental settings. In addition to its application in quality control and for regulatory purposes, two-stage in vitro testing has also been shown to be a valuable technique to evaluate the supersaturation and precipitation behavior of poorly soluble drugs during drug development. KEY
FINDINGS: The so-called 'transfer model', which is an example of two-stage testing, has provided valuable information about the in vivo performance of poorly soluble, weakly basic drugs by simulating the gastrointestinal drug transit from the stomach into the small intestine with a peristaltic pump. The evolution of the transfer model has resulted in various modifications of the experimental model set-up. Concomitantly, various research groups have developed simplified approaches to two-stage testing to investigate the supersaturation and precipitation behavior of weakly basic drugs without the necessity of using a transfer pump.
SUMMARY: Given the diversity among the various two-stage test methods available today, a more harmonized approach needs to be taken to optimize the use of two stage testing at different stages of drug development.
© 2018 Royal Pharmaceutical Society.

Keywords:  biopharmaceutics and drug disposition; in vivo/in vitro correlation

Mesh:

Year:  2018        PMID: 29380369     DOI: 10.1111/jphp.12875

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  2 in total

1.  Impact of Food and Drink Administration Vehicles on Paediatric Formulation Performance Part 2: Dissolution of Montelukast Sodium and Mesalazine Formulations.

Authors:  J Martir; T Flanagan; J Mann; Nikoletta Fotaki
Journal:  AAPS PharmSciTech       Date:  2020-10-15       Impact factor: 3.246

2.  Sustainable Stabilizer-Free Nanoparticle Formulations of Valsartan Using Eudragit® RLPO.

Authors:  Eszter Hajba-Horváth; Andrea Fodor-Kardos; Nishant Shah; Matthias G Wacker; Tivadar Feczkó
Journal:  Int J Mol Sci       Date:  2021-12-02       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.